StockData
Bio Essence Corp logo

Bio Essence Corp (BIOE) stock

BIOEOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 9/30
$0.42+0.03 (+7.72%)

Close on Oct 19, 2026Market cap $22.70MP/E 10.5Yield –

Bio Essence total assets

Total assets on the balance sheet at the end of each period.

Bio Essence's total assets was $4.00M at Sep 30, 2026. For fiscal 2025 it was $422.47K, up 50.3% from the year before. The highest annual figure on record is $2.76M in fiscal 2023.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$422.47K+50.3%
FY2024Dec 31, 2024$281.02K-89.8%
FY2023Dec 31, 2023$2.76M+78.2%
FY2022Dec 31, 2022$1.55M-8.9%
FY2021Dec 31, 2021$1.70M-7.9%
FY2020Dec 31, 2020$1.85M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$4.00M+2067.8%
Q2 FY2026Jun 30, 2026$4.00M+3452.1%
Q1 FY2026Mar 31, 2026$789.03K+115.7%
Q4 FY2025Dec 31, 2025$422.47K+50.3%
Q3 FY2025Sep 30, 2025$184.53K-74.2%
Q2 FY2025Jun 30, 2025$112.69K-94.6%
Q1 FY2025Mar 31, 2025$365.72K-83.8%
Q4 FY2024Dec 31, 2024$281.02K-89.8%
Q3 FY2024Sep 30, 2024$715.97K-65.1%
Q2 FY2024Jun 30, 2024$2.10M+40.3%
Q1 FY2024Mar 31, 2024$2.25M+46.2%
Q4 FY2023Dec 31, 2023$2.76M+78.2%
Q3 FY2023Sep 30, 2023$2.05M+24.5%
Q2 FY2023Jun 30, 2023$1.49M-12.7%
Q1 FY2023Mar 31, 2023$1.54M-13.4%
Q4 FY2022Dec 31, 2022$1.55M-8.9%
Q3 FY2022Sep 30, 2022$1.65M-7.1%
Q2 FY2022Jun 30, 2022$1.71M-1.0%
Q1 FY2022Mar 31, 2022$1.78M-0.4%
Q4 FY2021Dec 31, 2021$1.70M-7.9%
Q3 FY2021Sep 30, 2021$1.77M–
Q2 FY2021Jun 30, 2021$1.73M–
Q1 FY2021Mar 31, 2021$1.79M–
Q4 FY2020Dec 31, 2020$1.85M–

More Bio Essence figures

See a number that looks wrong?